What is copyright? copyright, generically known as semaglutide, is a medication that was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the treatment of adults with type 2 diabetes. It is administered via a weekly injection and works primarily by enhancing insulin production in response to https://omcpharmacy.org/product/ozempic_for_weight_loss/